USPTO serial 79344191
JULÄINE OF SWEDEN
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Dec 24, 2024
- Examiner
- ARRISON, RACHEL MARIE
- Law office
- FILE REPOSITORY (FRANCONIA)
What this means
Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.
Need help with JULÄINE OF SWEDEN?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Rachel Zacuto
Rachel Zacuto Knobbe, Martens, Olson & Bear, LLP2040 Main Street, 14th FloorIrvine, CA 92614United StatesGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | injectable dermal fillers; Pharmaceutical preparations in the nature of an injectable dermal filler; pharmaceutical preparations, namely, injectable poly-l-lactic acid for use in non-surgical restorative and beauty care treatment of wrinkles fine lines, folds, scars, lips, for face and body contouring, rejuvenating the skin and stimulation of collagen production; Pharmaceutical preparations for skin care; Pharmaceutical preparations for skin wounds; Pharmaceutical preparations for treating skin disorders; Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Dermatological pharmaceutical products for use in filling out wrinkles, folds, scars, and lips, for face and body contouring, for rejuvenating the skin and for stimulation of collagen production; Dermatological pharmaceutical products, namely, biostimulatory injectable dermal filler implant; Dermatological pharmaceutical products, namely, injectable poly-l-lactic acid for use in non-surgical treatment of wrinkles, fine lines, folds, and scars; Dermatological pharmaceutical products, namely, injectable poly-l-lactic acid for use in non-surgical restorative and aesthetic treatment of lips, face, and skin; Dermatological pharmaceutical products, namely, injectable poly-l-lactic acid for use in non-surgical restorative and aesthetic face and body contouring; Dermatological pharmaceutical products, namely, injectable poly-l-lactic acid for use in non-surgical skin rejuvenation; Dermatological pharmaceutical products, namely, injectable poly-l-lactic acid for stimulation of collagen production; Dermatological pharmaceutical products, namely, injectable dermal implant for the treatment of wrinkles, fine lines, folds, and scars; Dermatological pharmaceutical products, namely, injectable dermal implant for restorative and aesthetic treatment of lips, face, and skin; Dermatological pharmaceutical products, namely, injectable dermal implant for restorative and aesthetic face and body contouring; Dermatological pharmaceutical products, namely, injectable dermal implant for non-surgical skin rejuvenation; Dermatological pharmaceutical products, namely injectable dermal implant for stimulation of collagen production | ACTIVE | — |
| 010 | Medical apparatus and devices, namely, injection needles prefilled with biostimulatory injectable dermal filler implant; Medical apparatus and devices, namely, injection needles prefilled with biostimulatory injectable dermal filler implant medical device; Medical apparatus and devices, namely, injection needles prefilled with injectable poly-l-lactic acid for use in non-surgical treatment of wrinkles, fine lines, folds, and scars; Medical apparatus and devices, namely, injection needles prefilled with injectable poly-l-lactic acid for use in non-surgical restorative and aesthetic treatment of lips, face, and skin; Medical apparatus and devices, namely, injection needles prefilled with injectable poly-l-lactic acid for use in non-surgical restorative and aesthetic face and body contouring; Medical apparatus and devices, namely, injection needles prefilled with injectable poly-l-lactic acid for use in non-surgical skin rejuvenation; Medical apparatus and devices, namely, injection needles prefilled with injectable poly-llactic acid for stimulation of collagen production; Medical apparatus and devices, namely, injection needles prefilled with injectable dermal implant for the treatment of wrinkles, fine lines, folds, and scars; Medical apparatus and devices, namely, injection needles prefilled with injectable dermal implant for restorative and aesthetic treatment of lips, face, and skin; Medical apparatus and devices, namely, injection needles prefilled with injectable dermal implant for restorative and aesthetic face and body contouring; Medical apparatus and devices, namely, injection needles prefilled with injectable dermal implant for non-surgical skin rejuvenation; Medical apparatus and devices, namely, injection needles prefilled with injectable dermal implant for stimulation of collagen production; medical therapy instruments in the nature of an injection needle; hypodermic injection apparatus, namely, hypodermic needles, medical syringes and disposable syringes; hypodermic syringes for injections for medical purposes; injection needles for medical use | ACTIVE | — |
| 044 | Dermatological services for treating skin conditions; beauty consultancy; beauty treatment services of the body and face; beauty care services; beauty information services; beauty therapy treatments, namely, cosmetic body care services in the nature of cosmetic skin care services, including non-surgical treatment of fine lines and wrinkles; Skin treatments, namely, the injection of dermal filling agents and neuromuscular blocking agents to reduce the appearance of facial lines and wrinkles; beauty therapy treatment services, namely, non-invasive cosmetic body care services and cosmetic face care services; beauty therapy treatment services, namely cosmetic skincare treatment services in the nature of providing an injectable dermal filler to reduce the appearance of facial fine lines; cosmetic skin care services, namely, injection of dermal filling treatment for cosmetic skin care | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Nordberg Medical AB
- Other trademarks owned by Nordberg Medical AB
- Other trademarks owned by Nordberg Medical AB
- Other trademarks in Class 005
- Other trademarks in Class 010
- Other trademarks in Class 044
- Similar marks named JULÄINE OF SWEDEN
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Mar 5, 2026 | CRCV | CORRECTION TRANSACTION RECEIVED FROM IB | — |
| Jun 27, 2025 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Jun 10, 2025 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Jun 9, 2025 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Mar 24, 2025 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Dec 24, 2024 | NRCC | NOTICE OF REGISTRATION CONFIRMATION EMAILED | — |
| Dec 24, 2024 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Oct 22, 2024 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Oct 22, 2024 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Oct 2, 2024 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Sep 16, 2024 | EXPT | EXPARTE APPEAL TERMINATED | — |
| Sep 16, 2024 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Sep 16, 2024 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Sep 16, 2024 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Aug 13, 2024 | ERFR | TEAS REQUEST FOR RECONSIDERATION RECEIVED | — |
| Aug 13, 2024 | EXPI | EX PARTE APPEAL-INSTITUTED | — |
| Aug 13, 2024 | JURT | JURISDICTION RESTORED TO EXAMINING ATTORNEY | — |
| Aug 13, 2024 | EXAF | EXPARTE APPEAL RECEIVED AT TTAB | — |
| Feb 13, 2024 | GNFN | NOTIFICATION OF FINAL REFUSAL EMAILED | — |
| Feb 13, 2024 | GNFR | FINAL REFUSAL E-MAILED | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Feb 13, 2024 | CNFR | FINAL REFUSAL WRITTEN | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Jan 9, 2024 | DOCK | ASSIGNED TO EXAMINER | — |
| Jan 2, 2024 | OPNX | NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB | — |
| Dec 13, 2023 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Dec 13, 2023 | OPNR | NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB | — |
| Nov 8, 2023 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Nov 7, 2023 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Nov 7, 2023 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| May 31, 2023 | RFNT | REFUSAL PROCESSED BY IB | — |
| May 8, 2023 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| May 8, 2023 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Mar 18, 2023 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Mar 17, 2023 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Mar 10, 2023 | DOCK | ASSIGNED TO EXAMINER | — |
| Jul 12, 2022 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Jul 8, 2022 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Jul 7, 2022 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |